Development of Glycodendrimers as Potential Anti-HIV Microbicide Agents
Development of Glycodendrimers as Potential Anti-HIV Microbicide Agents
批准号:
9140913
负责人:
KATHERINE D MCREYNOLDS
金额:
$10.58万
依托单位国家:
美国
项目类别:
财政年份:
2016
资助国家:
美国
项目状态:
已结题
起止时间:
2016-04-01 至 2020-03-31
关键词:
AIDS/HIV problemAcidsAdoptedAnti-HIV AgentsAutomobile DrivingBindingBiologicalBiological AssayCCR5 geneCXCR4 geneCell surfaceCellsCellular StructuresChemistryCoitusDendrimersDevelopmentDiseaseElectrostaticsEnzyme-Linked Immunosorbent AssayEnzymesGlycoside HydrolasesHIVHIV Envelope Protein gp120HIV InfectionsHIV-1Half-LifeHeparan Sulfate ProteoglycanHydrazonesIndividualInfectionInorganic SulfatesLaboratoriesLeadLifeLinkLiteratureLocal MicrobicidesMediatingMembrane ProteinsMethodologyMethodsModificationMolecularOligosaccharidesOrganic solvent productOutcomeOximesPolymersPreventionPrevention strategyProceduresProcessPropertyReactionReaction TimeResearchResearch PriorityRunningSolventsStagingStrategic PlanningStructureTimeToxic effectUnited States National Institutes of HealthUniversitiesUnspecified or Sulfate Ion SulfatesVaccinesViralViral PhysiologyVulnerable PopulationsWaterWomanWorkanti-HIV microbicidebasechemokinecost effectivecytotoxicitydesigndrug candidateimprovedinnovationmicrobicidemicrowave electromagnetic radiationnovelpathogenpreventprophylacticpublic health relevancescreeningsugarsulfationtransmission processvirus development
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): There are approximately 37 million people living with HIV/AIDS worldwide. Up to half of these individuals are unaware of their HIV status and are unknowingly spreading the disease, primarily through sexual intercourse. As there is no vaccine available to prevent transmission of the virus, the development of other preventative strategies is of critical importance. Work in the McReynolds laboratory is focused on the development of novel glycodendrimer-based molecules as potential topical anti-HIV microbicide agents. The current NIH strategic plan lists the development of anti-HIV microbicides as a fiscal year 2016 research priority. The proposed glycodendrimer molecules are molecular mimics of key polyanionic host cell surface structures, the chemokine coreceptors (CXCR4 and CCR5), as well as the ubiquitous cell surface molecules, heparan sulfate proteoglycans (HSPGs). The electrostatic interactions between these host cell structures and the trimeric and polybasic HIV-1 surface protein, gp120, occur multivalently and lead to viral attachment and ultimately, infection.
The proposed glycodendrimers are designed to be both multivalent and polyanionic and therefore will have the capacity to block these host cell-to-viral points of contact and prevent th earliest stages of attachment and infection from occurring. There are two primary objectives of the project. The first is the synthesis of unique multivalent polyanionic glycodendrimers comprised of either native or synthetic oligosaccharides, which will function as molecular mimics of host cell chemokine coreceptors/HSPGs. The second is to adopt principles of green chemistry into the synthetic methodologies. Green chemistry represents a versatile, efficient and cost effective strategy to make glycodendrimers in fewer steps and in better yields, all while minimizing the use of organic solvents and shortening the reaction times. This will lead to the expedited development of compounds with improved anti- HIV activities. The green methods that will be incorporated into the synthesis of the glycodendrimers are: 1. Minimization of the number of reaction steps by decreasing the use of protecting groups and incorporation of a chemoselective linkage. 2. Running reactions neat, or with water as a solvent. 3. Incorporating enzyme- catalyzed reactions. 4. Using microwave-mediated reactions to shorten the reaction times and improve the yields. Successful completion of this project has the potential to yield a new class of microbicide agents capable of preventing millions of new HIV infections worldwide.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Glycopolymer Inhibitors of Heparan Sulfate Proteoglycan Binding Pathogens
-
批准号:10684252
-
项目类别:
-
资助金额:$10.65万
-
财政年份:2016
-
负责人:KATHERINE D MCREYNOLDS
-
依托单位:
Glycopolymer Inhibitors of Heparan Sulfate Proteoglycan Binding Pathogens
-
批准号:10491359
-
项目类别:
-
资助金额:$10.65万
-
财政年份:2016
-
负责人:KATHERINE D MCREYNOLDS
-
依托单位:
Development of Glycodendrimers as Potential Anti-HIV Microbicide Agents
-
批准号:9247821
-
项目类别:
-
资助金额:$10.63万
-
财政年份:2016
-
负责人:KATHERINE D MCREYNOLDS
-
依托单位:
Glycopolymer Inhibitors of Heparan Sulfate Proteoglycan Binding Pathogens
-
批准号:10333201
-
项目类别:
-
资助金额:$10.65万
-
财政年份:2016
-
负责人:KATHERINE D MCREYNOLDS
-
依托单位:
Synthesis of Novel Water-Soluble Glycodendrimers as Anti-HIV Agents
-
批准号:7848773
-
项目类别:
-
资助金额:$1.77万
-
财政年份:2009
-
负责人:KATHERINE D MCREYNOLDS
-
依托单位:
Synthesis of Novel Water-Soluble Glycodendrimers as Anti-HIV Agents
-
批准号:7278054
-
项目类别:
-
资助金额:$3.69万
-
财政年份:2006
-
负责人:KATHERINE D MCREYNOLDS
-
依托单位:
Synthesis of Novel Water-Soluble Glycodendrimers as Anti-HIV Agents
-
批准号:7061971
-
项目类别:
-
资助金额:$19.8万
-
财政年份:2006
-
负责人:KATHERINE D MCREYNOLDS
-
依托单位:
国内基金
海外基金
登录
查看更多内容
具有抗癌活性的天然产物金霉酸(Aureolic acids)全合成与选择性构建2-脱氧糖苷键
-
批准号:22007039
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:王黎明
-
依托单位:
海洋放线菌来源聚酮类化合物Pteridic acids生物合成机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2019
-
负责人:朱义广
-
依托单位:
手性Lewis Acids催化的分子内串联1,5-氢迁移/环合反应及其在构建结构多样性手性含氮杂环化合物中的应用
-
批准号:21372217
-
项目类别:面上项目
-
资助金额:80.0万元
-
批准年份:2013
-
负责人:袁伟成
-
依托单位:
对空气稳定的新型的有机金属Lewis Acids催化剂制备、表征与应用研究
-
批准号:21172061
-
项目类别:面上项目
-
资助金额:30.0万元
-
批准年份:2011
-
负责人:许新华
-
依托单位:
钛及含钛Lewis acids促臭氧/过氧化氢体系氧化性能的广普性、高效性及其机制
-
批准号:21176225
-
项目类别:面上项目
-
资助金额:60.0万元
-
批准年份:2011
-
负责人:童少平
-
依托单位:
基于Zip Nucleic Acids引物对高度降解和低拷贝DNA检材的STR分型研究
-
批准号:81072511
-
项目类别:面上项目
-
资助金额:31.0万元
-
批准年份:2010
-
负责人:严江伟
-
依托单位:
海洋天然产物Makaluvic acids 的全合成及其对南海鱼虱存活的影响
-
批准号:30660215
-
项目类别:地区科学基金项目
-
资助金额:21.0万元
-
批准年份:2006
-
负责人:王世范
-
依托单位: